Pech T et al. |
Combination therapy of tacrolimus and infliximab reduces inflammatory response and dysmotility in experimental small bowel transplantation in rats. |
2012 |
Transplantation |
pmid:22167049
|
Charlton M et al. |
Everolimus Is Associated With Less Weight Gain Than Tacrolimus 2 Years After Liver Transplantation: Results of a Randomized Multicenter Study. |
2017 |
Transplantation |
pmid:28817434
|
Singh N et al. |
Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. |
2000 |
Transplantation |
pmid:10708096
|
Zoppo A et al. |
Trimetazidine counteracts tacrolimus nephrotoxicity in a hypertensive liver transplant patient. |
1999 |
Transplantation |
pmid:10551656
|
Ciancio G et al. |
Randomized trial of three induction antibodies in kidney transplantation: long-term results. |
2014 |
Transplantation |
pmid:24477186
|
Gonwa T et al. |
Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months. |
2003 |
Transplantation |
pmid:12717205
|
Tzakis AG et al. |
Preliminary experience with campath 1H (C1H) in intestinal and liver transplantation. |
2003 |
Transplantation |
pmid:12717207
|
Dresske B et al. |
WOFIE synergizes with calcineurin-inhibitor treatment and early steroid withdrawal in kidney transplantation. |
2003 |
Transplantation |
pmid:12717217
|
Gruessner RW et al. |
A prospective study of FK506 versus CsA and pig ATG in a porcine model of small bowel transplantation. |
1995 |
Transplantation |
pmid:7530871
|
Jindal RM et al. |
Serum lipid changes in liver transplant recipients in a prospective trial of cyclosporine versus FK506. |
1994 |
Transplantation |
pmid:7514317
|
Eason JD et al. |
Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy. |
2003 |
Transplantation |
pmid:12717237
|
Todo S et al. |
Abdominal multivisceral transplantation. |
1995 |
Transplantation |
pmid:7530873
|
Khanna A et al. |
Donor bone marrow potentiates the effect of tacrolimus on nonvascularized heart allograft survival: association with microchimerism and growth of donor dendritic cell progenitors from recipient bone marrow. |
1998 |
Transplantation |
pmid:9500620
|
Gayowski T et al. |
Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity. |
1998 |
Transplantation |
pmid:9500623
|
Neylan JF |
Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group. |
1998 |
Transplantation |
pmid:9500626
|
Hougardy JM et al. |
The once-daily formulation of tacrolimus: a step forward in kidney transplantation? |
2012 |
Transplantation |
pmid:22234346
|
Shihab FS et al. |
Mechanism of fibrosis in experimental tacrolimus nephrotoxicity. |
1997 |
Transplantation |
pmid:9422427
|
Vu MD et al. |
Tacrolimus (FK506) and sirolimus (rapamycin) in combination are not antagonistic but produce extended graft survival in cardiac transplantation in the rat. |
1997 |
Transplantation |
pmid:9422432
|
D'Antiga L et al. |
Late cellular rejection in paediatric liver transplantation: aetiology and outcome. |
2002 |
Transplantation |
pmid:11792983
|
Deuse T et al. |
The interaction between FK778 and tacrolimus in the prevention of rat cardiac allograft rejection is dose dependent. |
2004 |
Transplantation |
pmid:15084926
|
Ferraris JR et al. |
Conversion from cyclosporine A to tacrolimus in pediatric kidney transplant recipients with chronic rejection: changes in the immune responses. |
2004 |
Transplantation |
pmid:15084930
|
Reese JC et al. |
The effect of FK506 on canine bile flow. |
1993 |
Transplantation |
pmid:7504342
|
Shapiro R et al. |
Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. |
1999 |
Transplantation |
pmid:10628763
|
Woodle ES et al. |
FK506--reversal of humorally mediated cardiac allograft rejection in the presence of preformed anti-class I antibody. |
1993 |
Transplantation |
pmid:7504346
|
Valdivia LA et al. |
Successful hamster-to-rat liver xenotransplantation under FK506 immunosuppression induces unresponsiveness to hamster heart and skin. |
1993 |
Transplantation |
pmid:7681230
|
Shapiro R et al. |
A prospective randomized trial of FK506-based immunosuppression after renal transplantation. |
1995 |
Transplantation |
pmid:7533343
|
Cox KL et al. |
An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. |
1995 |
Transplantation |
pmid:7533344
|
Sakr M et al. |
The protective effect of FK506 pretreatment against renal ischemia/reperfusion injury in rats. |
1992 |
Transplantation |
pmid:1374948
|
McDiarmid SV et al. |
FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial. |
1995 |
Transplantation |
pmid:7533345
|
Andrés A et al. |
A randomized trial comparing renal function in older kidney transplant patients following delayed versus immediate tacrolimus administration. |
2009 |
Transplantation |
pmid:19898206
|
Eberhard OK et al. |
How best to use tacrolimus (FK506) for treatment of steroid- and OKT3-resistant rejection after renal transplantation. |
1996 |
Transplantation |
pmid:8629294
|
Newell KA et al. |
Treatment with either anti-CD4 or anti-CD8 monoclonal antibodies blocks alphabeta T cell-mediated rejection of intestinal allografts in mice. |
1997 |
Transplantation |
pmid:9381541
|
Iyengar AR et al. |
Striking augmentation of hematopoietic cell chimerism in noncytoablated allogeneic bone marrow recipients by FLT3 ligand and tacrolimus. |
1997 |
Transplantation |
pmid:9158008
|
van Hooff JP |
Pneumocystis carinii pneumonia after renal transplantation. |
1997 |
Transplantation |
pmid:9158038
|
Conrotto D et al. |
Dramatic increase of tacrolimus plasma concentration during topical treatment for oral graft-versus-host disease. |
2006 |
Transplantation |
pmid:17060865
|
Khanna A et al. |
Tacrolimus induces increased expression of transforming growth factor-beta1 in mammalian lymphoid as well as nonlymphoid cells. |
1999 |
Transplantation |
pmid:10071036
|
Kessler M et al. |
A renal allograft recipient with late recurrence of focal and segmental glomerulosclerosis after switching from cyclosporine to tacrolimus. |
1999 |
Transplantation |
pmid:10071045
|
Hill CC et al. |
Penile prosthesis surgery in the immunosuppressed patient. |
1993 |
Transplantation |
pmid:7692633
|
Yanchar NL et al. |
Tacrolimus (FK506)--its effects on intestinal glucose transport. |
1996 |
Transplantation |
pmid:8610392
|
Roberts JP et al. |
Reversal of chronic rejection after treatment failure with FK506 and RS61443. |
1993 |
Transplantation |
pmid:7692634
|
Hariharan S et al. |
Rescue therapy with tacrolimus after combined kidney/pancreas and isolated pancreas transplantation in patients with severe cyclosporine nephrotoxicity. |
1996 |
Transplantation |
pmid:8610411
|
Reyes J et al. |
Expressive dysphasia possibly related to FK506 in two liver transplant recipients. |
1990 |
Transplantation |
pmid:1701571
|
Cacciarelli TV et al. |
Oral tacrolimus (FK506) induction therapy in pediatric orthotopic liver transplantation. |
1996 |
Transplantation |
pmid:8610416
|
Jiang H et al. |
Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production. |
2002 |
Transplantation |
pmid:12085006
|
Grudé P et al. |
MDR1 gene expression in peripheral blood mononuclear cells after liver transplantation. |
2002 |
Transplantation |
pmid:12085008
|
Xu X et al. |
FKBP12 is the only FK506 binding protein mediating T-cell inhibition by the immunosuppressant FK506. |
2002 |
Transplantation |
pmid:12085010
|
Cassuto E et al. |
Adherence to and Acceptance of Once-Daily Tacrolimus After Kidney and Liver Transplant: Results From OSIRIS, a French Observational Study. |
2016 |
Transplantation |
pmid:27653227
|
Stojanovic J et al. |
Immune Desensitization Allows Pediatric Blood Group Incompatible Kidney Transplantation. |
2017 |
Transplantation |
pmid:27463537
|
Bechstein WO et al. |
Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: 1-year results of a large multicenter trial. |
2004 |
Transplantation |
pmid:15114089
|
Saliba F et al. |
Corticosteroid-Sparing and Optimization of Mycophenolic Acid Exposure in Liver Transplant Recipients Receiving Mycophenolate Mofetil and Tacrolimus: A Randomized, Multicenter Study. |
2016 |
Transplantation |
pmid:27454919
|
Lo A et al. |
Comparison of sirolimus-based calcineurin inhibitor-sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation. |
2004 |
Transplantation |
pmid:15114090
|
Jin S et al. |
Effect of tacrolimus on the expression of macrophage scavenger and nuclear hormone receptors in THP-1-derived human macrophages. |
2004 |
Transplantation |
pmid:15114099
|
Shoker A et al. |
Heightened CD40 ligand gene expression in peripheral CD4+ T cells from patients with kidney allograft rejection. |
2000 |
Transplantation |
pmid:10949194
|
Straatman LP and Coles JG |
Pediatric utilization of rapamycin for severe cardiac allograft rejection. |
2000 |
Transplantation |
pmid:10949201
|
Burke GW et al. |
Microangiopathy in kidney and simultaneous pancreas/kidney recipients treated with tacrolimus: evidence of endothelin and cytokine involvement. |
1999 |
Transplantation |
pmid:10573073
|
Levitsky J et al. |
Allospecific regulatory effects of sirolimus and tacrolimus in the human mixed lymphocyte reaction. |
2011 |
Transplantation |
pmid:21239962
|
Tokita D et al. |
High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance. |
2008 |
Transplantation |
pmid:18301333
|
Chan K et al. |
Kidney transplantation with minimized maintenance: alemtuzumab induction with tacrolimus monotherapy--an open label, randomized trial. |
2011 |
Transplantation |
pmid:21836540
|
Jain AB et al. |
A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim report. |
1998 |
Transplantation |
pmid:9846530
|
Takatsuki M et al. |
Weaning of immunosuppression in living donor liver transplant recipients. |
2001 |
Transplantation |
pmid:11502975
|
Borger P et al. |
Cyclosporine, FK506, mycophenolate mofetil, and prednisolone differentially modulate cytokine gene expression in human airway-derived epithelial cells. |
2000 |
Transplantation |
pmid:10798763
|
Moffatt SD et al. |
STAT 6 up-regulation by FK506 in the presence of interleukin-4. |
2000 |
Transplantation |
pmid:10798785
|
Woodle ES et al. |
FK506: inhibition of humoral mechanisms of hepatic allograft rejection. |
1992 |
Transplantation |
pmid:1379749
|
Jugie M et al. |
Study of the impact of liver transplantation on the outcome of intestinal grafts in children. |
2006 |
Transplantation |
pmid:16612274
|
Augustine JJ et al. |
Improved renal function after conversion from tacrolimus/sirolimus to tacrolimus/mycophenolate mofetil in kidney transplant recipients. |
2006 |
Transplantation |
pmid:16612276
|
Meier M et al. |
Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: a randomized controlled trial. |
2006 |
Transplantation |
pmid:16612281
|
Shapiro R et al. |
"Suboptimal" kidney donors: the experience with tacrolimus-based immunosuppression. |
1996 |
Transplantation |
pmid:8932264
|
Devlin J and Williams R |
Transplantation for fulminant hepatic failure: comparing tacrolimus versus cyclosporine for immunosuppression and the outcome in elective transplants. European FK506 Liver Study Group. |
1996 |
Transplantation |
pmid:8932266
|
Vyas S et al. |
Outcome of twin pregnancy in a renal transplant recipient treated with tacrolimus. |
1999 |
Transplantation |
pmid:10030303
|
Stempfle HU et al. |
The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol. |
2002 |
Transplantation |
pmid:11889427
|
Kasahara M et al. |
Role of HLA compatibility in pediatric living-related liver transplantation. |
2002 |
Transplantation |
pmid:12438966
|
Brunet M et al. |
Sequential determination of pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients treated with mycophenolate mofetil. |
2006 |
Transplantation |
pmid:16495801
|
Xu H et al. |
Simultaneous bone marrow and composite tissue transplantation in rats treated with nonmyeloablative conditioning promotes tolerance. |
2013 |
Transplantation |
pmid:23250336
|
Ko S et al. |
The enhanced immunosuppressive efficacy of newly developed liposomal FK506 in canine liver transplantation. |
1995 |
Transplantation |
pmid:7539553
|
Chen H et al. |
Compromised kidney graft rejection response in Vervet monkeys after withdrawal of immunosuppressants tacrolimus and sirolimus. |
2000 |
Transplantation |
pmid:10836361
|
Fealy MJ et al. |
Association of down-regulation of cytokine activity with rat hind limb allograft survival. |
1995 |
Transplantation |
pmid:7539555
|
Hougardy JM et al. |
Conversion from Prograf to Advagraf among kidney transplant recipients results in sustained decrease in tacrolimus exposure. |
2011 |
Transplantation |
pmid:21192316
|
Vanrenterghem Y et al. |
The effects of FK778 in combination with tacrolimus and steroids: a phase II multicenter study in renal transplant patients. |
2004 |
Transplantation |
pmid:15257032
|
Bayés B et al. |
Adiponectin and risk of new-onset diabetes mellitus after kidney transplantation. |
2004 |
Transplantation |
pmid:15257035
|
van Hooff JP et al. |
Tacrolimus and posttransplant diabetes mellitus in renal transplantation. |
2005 |
Transplantation |
pmid:15940032
|
Mourer JS et al. |
Impact of late calcineurin inhibitor withdrawal on ambulatory blood pressure and carotid intima media thickness in renal transplant recipients. |
2013 |
Transplantation |
pmid:23715049
|
Wang X et al. |
Immunosuppression with a combination of pg490-88 and a subtherapeutic dose of FK506 in a canine renal allograft model. |
2005 |
Transplantation |
pmid:15940043
|
Gaber AO et al. |
Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): a phase 2 trial of stable renal transplant recipients. |
2013 |
Transplantation |
pmid:23715050
|
Abu-Elmagd K et al. |
The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. |
1991 |
Transplantation |
pmid:1713365
|
Maluccio M et al. |
Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression. |
2003 |
Transplantation |
pmid:12923450
|
Pascher A et al. |
Successful infliximab treatment of steroid and OKT3 refractory acute cellular rejection in two patients after intestinal transplantation. |
2003 |
Transplantation |
pmid:12923454
|
Langrehr JM et al. |
Clinical course, morphology, and treatment of chronically rejecting small bowel allografts. |
1993 |
Transplantation |
pmid:7679526
|
Uemoto S et al. |
Experience with FK506 in living-related liver transplantation. |
1993 |
Transplantation |
pmid:7679528
|
Wiesner RH |
A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group. |
1998 |
Transplantation |
pmid:9734494
|
|
Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Drug levels in PHAs who receive liver transplants. |
2003 Apr-May |
TreatmentUpdate |
pmid:17216847
|
Kunz J and Hall MN |
Cyclosporin A, FK506 and rapamycin: more than just immunosuppression. |
1993 |
Trends Biochem. Sci. |
pmid:7694398
|
Cardenas ME et al. |
Signal-transduction cascades as targets for therapeutic intervention by natural products. |
1998 |
Trends Biotechnol. |
pmid:9807840
|
Snyder SH et al. |
Neural actions of immunophilin ligands. |
1998 |
Trends Pharmacol. Sci. |
pmid:9509898
|
Liu J |
FK506 and ciclosporin: molecular probes for studying intracellular signal transduction. |
1993 |
Trends Pharmacol. Sci. |
pmid:7692652
|
Chang JY et al. |
FK506 and rapamycin: novel pharmacological probes of the immune response. |
1991 |
Trends Pharmacol. Sci. |
pmid:1710854
|
Sommerer C et al. |
Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial. |
2016 |
Trials |
pmid:26888217
|
Nashan B et al. |
Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial. |
2015 |
Trials |
pmid:25873064
|
Bajetta E et al. |
Merkel cell carcinoma after liver transplantation: a case report. |
2007 May-Jun |
Tumori |
pmid:17679476
|
Vennarecci G et al. |
[Acute liver toxicity of antiretroviral therapy (HAART) after liver transplantation in a patient with HIV-HCV coinfection and associated hepatocarcinoma (HCC)]. |
2003 Jul-Aug |
Tumori |
pmid:12903579
|
Tümgör G et al. |
A case of uneventful ABO-incompatible liver transplantation from a deceased donor managed with routine immunosuppressive treatment. |
2014 |
Turk J Gastroenterol |
pmid:25599790
|